
LeMaitre Vascular LMAT
€ 81.23
-2.84%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Land |
|
IPO-Jahr |
2006 |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBALSPB |
Anteile |
22.6 M |
Marktkapitalisierung |
$ 2.12 B |
EBITDA (LTM) |
$ 74.9 M |
P/E (LTM) |
43.05 |
P/S (LTM) |
9.91 |
EPS (LTM) |
2.56 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 67.92 | -1.02 % | $ 13.5 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 122.21 | -3.34 % | $ 6.99 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 417.12 | -2.22 % | $ 149 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 66.57 | -1.96 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 142.83 | 0.58 % | $ 3.52 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.97 | -0.88 % | $ 183 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 114.34 | 0.45 % | $ 3.66 B | Nasdaq Global Select Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.8 | -1.1 % | $ 82.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.4 | 2.43 % | $ 32.8 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 67.35 | -0.24 % | $ 3.98 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 9.9 | 3.99 % | $ 84 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.52 | -0.28 % | $ 4.12 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 79.32 | 0.74 % | $ 3.74 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 209.69 | -1.5 % | $ 20.6 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 29.75 | -0.4 % | $ 1.47 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.9 | -1.22 % | $ 184 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 135.23 | -0.38 % | $ 6.03 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.56 | 0.72 % | $ 222 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 330.41 | -1.35 % | $ 23.9 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.17 | -2.33 % | $ 1.7 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.31 | -1.53 % | $ 2.06 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 1.73 % | $ 21 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 62.36 | -4.06 % | $ 205 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 26.91 | -2.34 % | $ 1.29 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.84 | -0.54 % | $ 167 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.49 | 2.3 % | $ 10.5 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 194.98 | -1.0 % | $ 28.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.26 | -0.15 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.18 | 2.32 % | $ 274 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.39 | 0.36 % | $ 506 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 149.8 | -1.48 % | $ 43.1 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.24 | -0.46 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.09 | -3.66 % | $ 301 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 132.62 | 1.91 % | $ 7.46 M | Nasdaq Global Select Market,SPB |